Functionally, Gal-3 enhances tumor progression through several mechanisms, including inhibition of apoptosis, promotion of epithelial–mesenchymal transition (EMT), stimulation of angiogenesis, and modulation of immune responses [2,8]. The gene discussed is LGALS3; the disease is neoplasm.